NuVasive, Inc. (NASDAQ:NUVA) Receives $50.98 Consensus Target Price from Brokerages

NuVasive, Inc. (NASDAQ:NUVA – Free Report) has been given an average rating of “Hold” by the eleven analysts that are covering the company, Marketbeat reports. Nine equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price objective among analysts that […]

Related Keywords

,Nuvasive Inc ,Nasdaq ,Nuvasive Company Profile ,Asset Dedication ,Nisa Investment Advisors ,Barclays ,Quadrant Capital Group ,Beaird Harris Wealth Management ,Investment Advisers ,Free Report ,Capital Group ,Harris Wealth Management ,Investment Advisors ,Nuvasive Daily ,Nuvasive ,Nasdaq Nuva ,Tnuva ,Medical ,67070410 ,Ratings ,Consensus ,